ADWIA Pharmaceuticals

ADWIA Pharmaceuticals, established in 1984, is a prominent Egyptian entity operating within the pharmaceutical and healthcare sectors. The company focuses on the manufacturing of high-quality generic medications designed to enhance patient outcomes across diverse therapeutic categories. By maintaining a robust commitment to medical excellence, the organization serves as a critical provider for healthcare systems and patients requiring reliable pharmaceutical solutions. ADWIA Pharmaceuticals leverages decades of industry experience to address complex health challenges through a specialized portfolio of products.

The company’s product portfolio encompasses a wide range of therapeutic areas, including cardiology, orthopedics, urology, and gastroenterology. To ensure the highest levels of product safety and efficacy, ADWIA Pharmaceuticals strictly adheres to international regulatory standards, including Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and ISO certifications. These technical frameworks govern their production processes, ensuring that every pharmaceutical output meets rigorous quality benchmarks. Meet ADWIA Pharmaceuticals's team to understand the professional expertise driving these manufacturing standards and the organizational commitment to clinical excellence.

With a workforce of 500-1,000 employees, the company maintains a focused operational footprint with one primary location in Cairo, Egypt. This centralized structure allows for streamlined management of their manufacturing and distribution processes. ADWIA Pharmaceuticals continues to expand its influence in the regional healthcare market, leveraging its long-standing history to maintain competitive positioning. The company remains dedicated to advancing pharmaceutical care through consistent innovation and adherence to global health standards, ensuring that their therapeutic solutions remain accessible and effective for their target patient demographics.